Epanova | AMRN Message Board Posts

Amarin Corporation plc

  AMRN website

AMRN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  4401 of 4541  at  6/19/2019 12:31:39 PM  by

ex_hacker202


 In response to msg 4398 by  biobetter
view thread

Re: Epanova

  Currently, 1g of generic EPA plus DHA is prescribed for secondary prevention after a heart attack
 
By whom? Every trial using that dose of GL has failed, and the EU stopped covering GL at that dose because of a clear lack of efficacy. Author fails to mention that AMRN already blocked AZN from marketing E in the US over patent infringement - E is a non-starter regardless of STRENGTH results.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 116
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...